ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Claude Deville
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barandon, L.
Right arrow Articles by Duplàa, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barandon, L.
Right arrow Articles by Duplàa, C.
Related Collections
Right arrow Molecular biology

Ann Thorac Surg 2004;78:1409-1417
© 2004 The Society of Thoracic Surgeons


Original article: cardiovascular

Repair of Myocardial Infarction by Epicardial Deposition of Bone Marrow Cell-Coated Muscle Patch in a Murine Model

Laurent Barandon, MDa,b,*, Thierry Couffinhal, MD, PhDa,b, Pascale Dufourcq, PhDb, Philippe Alzieu, BSb, Danièle Daret, BSb, Claude Deville, MDa, Cécile Duplàa, PhDb

a Department of Cardiovascular Surgery and Cardiology, Haut-Lévêque Hospital, Pessac, France
b National Health Institute and Medical Research, Pessac, and University of Bordeaux 2 - Victor Segalen, Bordeaux, Cedex, France

Accepted for publication December 29, 2003.

* Address reprint requests to Dr Barandon, Cardiovascular Surgery Department, Haut-Lévêque Hospital, 33604 Pessac, France
lesbarandon{at}wanadoo.fr

BACKGROUND: Myocardial infarction results in irreversible myocyte loss. In a murine model, we tested the feasibility of a novel repair technique combining bone marrow cell (BMC) transplantation and cardiomyoplasty.

METHODS: Myocardial infarction was induced cryogenically in backcrossed ROSA 26 transgenic x C57BL/6J mice (n = 75). Thirty days later, surviving mice (n = 69) were randomized to sham treatment (rethoracotomy only; n = 11), patch only treatment (n = 29), or patch + BMC treatment (n = 29). Abdominal muscle patches were harvested from donor littermates not expressing the ß-galactosidase reporter gene and sutured on the epicardium directly above the infarct zone. Patch only–treated mice received uncoated patches. Patch + BMC–treated mice received patches coated with 5 x 106 ß-galactosidase-expressing BMCs embedded in a collagen-rich three-dimensional matrix.

RESULTS: Mortality rate was 52% after muscle patch implantation. Bone marrow cells were able to migrate from muscle patch into the infarct zone, as demonstrated by ß-galactosidase immunostaining, and ultimately constituted 8% of all cells in scar tissue (mean ± standard deviation, 219 ± 111/mm2). Angiogenesis and cell survival in the scar were improved by patch + BMC treatment. Left ventricular geometry and cardiac function were improved by patch treatment, with or without BMC, although the effects were stronger after patch + BMC treatment.

CONCLUSIONS: Epicardial deposition of a BMC-coated muscle patch is a promising approach to restoring cardiac function after myocardial infarction.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Derval, L. Barandon, P. Dufourcq, L. Leroux, J.-M. D. Lamaziere, D. Daret, T. Couffinhal, and C. Duplaa
Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model.
Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 248 - 254.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier
Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study
Ann. Thorac. Surg., March 1, 2008; 85(3): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Siepe, M.-N. Giraud, M. Pavlovic, C. Receputo, F. Beyersdorf, P. Menasche, T. Carrel, and H. T. Tevaearai
Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure
J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 124 - 131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.